MELISSA ROGERS: Open Payments
NPI 1871692020 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| ABBVIE INC. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Exact Sciences Corporation | 1 | $30 |
| Lilly USA, LLC | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Seqirus USA Inc | 1 | $20 |
| Novo Nordisk Inc | 1 | $15 |
Products named: BREZTRI, VRAYLAR, VPRIV, The Cologuard Plus Collection Kit, MOUNJARO, UBRELVY, CAPVAXIVE, Flucelvax.
Industry payments across MD — which companies pay providers there.
